Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (5,511) Arrow Down
Filter Results: (5,511) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (5,511)
    • People  (17)
    • News  (2,096)
    • Research  (2,742)
    • Events  (3)
    • Multimedia  (223)
  • Faculty Publications  (2,088)

Show Results For

  • All HBS Web  (5,511)
    • People  (17)
    • News  (2,096)
    • Research  (2,742)
    • Events  (3)
    • Multimedia  (223)
  • Faculty Publications  (2,088)
← Page 69 of 5,511 Results →
  • 27 Jul 2022
  • News

Alumna-Led Reproductive Health Startup Raises $4.7 Million

Victoria Thain Gioia (MBA 2015) Photo courtesy Perelel A recent article in Forbes reports that reproductive health startup Perelel, cofounded by Victoria Thain Gioia (MBA 2015), has raised a $4.7 million seed round led by Unilever... View Details
  • October 10, 2019
  • Article

The Case for the Public Option Over Medicare for All

By: Regina E. Herzlinger and Richard Boxer
How can the United States better control its health care costs and quality and still achieve universal coverage? The strongest choice is not Medicare for All, which would eliminate private insurance; it’s the public option, which would allow people to choose from... View Details
Keywords: Universal Health Coverage; Public Option; Medicare; Health Care and Treatment; Insurance; Cost Management; Quality; United States
Citation
Find at Harvard
Register to Read
Related
Herzlinger, Regina E., and Richard Boxer. "The Case for the Public Option Over Medicare for All." Harvard Business Review Digital Articles (October 10, 2019): 2–5.
  • September 2014
  • Supplement

Pfizer and AstraZeneca: Marketing an Acquisition (B)

By: John A. Quelch and James Weber
This (B) case provides a brief description of the outcome of the (A) case. View Details
Keywords: Health Care Policy; Pharmaceutical Sales; Mergers And Acquisitions; Marketing; Pharmaceutical Industry; United Kingdom; United States
Citation
Purchase
Related
Quelch, John A., and James Weber. "Pfizer and AstraZeneca: Marketing an Acquisition (B)." Harvard Business School Supplement 515-008, September 2014.
  • Article

Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected

By: Maximilian J. Pany, Michael E. Chernew and Leemore S. Dafny
Concern about high hospital prices for commercially insured patients has motivated several proposals to regulate these prices. Such proposals often limit regulations to highly concentrated hospital markets. Using a large sample of 2017 US commercial insurance claims,... View Details
Keywords: Health Care Providers; Hospitals; Insurance Market Regulation; Price Regulation; Markets; Health Care and Treatment; Cost; Quality; Insurance; Price; Governing Rules, Regulations, and Reforms
Citation
Find at Harvard
Read Now
Related
Pany, Maximilian J., Michael E. Chernew, and Leemore S. Dafny. "Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected." Health Affairs 40, no. 9 (September 2021): 1386–1394.
  • August 2018
  • Article

The Impact of the Entry of Biosimilars: Evidence from Europe

By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Citation
Find at Harvard
Register to Read
Related
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
  • 12 Jun 2020
  • News

What Blockchain Could Mean for Your Health Data

  • October 2013 (Revised January 2015)
  • Case

The Slingshot: Improving Water Access

By: John A. Quelch, Margaret L. Rodriguez and Carin-Isabel Knoop
In 2012, over 750 million people around the globe lacked access to safe drinking water. Dean Kamen, inventor of the Segway, sought to bring fresh water to poor and rural areas with the Slingshot, a water purification device. Kamen's challenge was to identify ways to... View Details
Keywords: Water; Public Health; Health Care; Slingshot; Dean Kamen; DEKA; Coca-Cola; Developing Markets; Freestyle; Safety; Natural Environment; Pollutants; Health; Distribution Channels; Developing Countries and Economies; Innovation and Invention; Africa; Latin America; South America; Asia
Citation
Educators
Purchase
Related
Quelch, John A., Margaret L. Rodriguez, and Carin-Isabel Knoop. "The Slingshot: Improving Water Access." Harvard Business School Case 514-007, October 2013. (Revised January 2015.)
  • 14 Jun 2021
  • News

Why the Hottest Primary Care Startups Aren't Chasing Medicaid

  • May 2007 (Revised July 2011)
  • Teaching Note

The West German Headache Center: Integrated Migraine Care (TN)

By: Michael E. Porter, Clemens Guth and Elisa M. Dannemiller
Teaching note to 707-559. View Details
Keywords: Health Care and Treatment; Germany
Citation
Purchase
Related
Porter, Michael E., Clemens Guth, and Elisa M. Dannemiller. "The West German Headache Center: Integrated Migraine Care (TN)." Harvard Business School Teaching Note 707-560, May 2007. (Revised July 2011.)
  • 2006
  • Case

In Reach Care of the Elderly: Moss Valley Medical Practice

By: Julie Battilana, A. M. Cagna and T. D'Aunno
Keywords: Health Care and Treatment; Age
Citation
Related
Battilana, Julie, A. M. Cagna, and T. D'Aunno. "In Reach Care of the Elderly: Moss Valley Medical Practice." INSEAD Case, 2006.
  • 06 Sep 2022
  • News

Our September Issue: Nurses, Care Delivery, Pharmaceuticals & More

  • 01 May 2010
  • News

The Multi-Stakeholder Movement For Primary Care Renewal And Reform

  • 01 Feb 2024
  • News

Retired Military Officials: Protecting Abortion Care Keeps America Safe

  • 2010
  • Working Paper

Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative

By: Nava Ashraf, Gunther Fink and David N. Weil
Since 2003, Zambia has been engaged in a large-scale, centrally coordinated national anti-malaria campaign which has become a model in sub-Saharan Africa. This paper aims at quantifying the individual and macro level benefits of this campaign, which involved mass... View Details
Keywords: Cost vs Benefits; Developing Countries and Economies; Health Care and Treatment; Health Disorders; Performance Evaluation; Programs; Health Industry; Zambia
Citation
Read Now
Related
Ashraf, Nava, Gunther Fink, and David N. Weil. "Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative." NBER Working Paper Series, No. 16069, June 2010.
  • February 2021 (Revised June 2021)
  • Case

Brainlab: Imaging a MedTech Future

By: Regina E. Herzlinger, Gregory P. Licholai and Federica Gabrieli
Can Brainlab, a privately held firm, compete with giants like Medtronic and Amazon in delivering the Digital Operating Room of the future? The CEO is pondering solutions for secure exchange of medical information, pricing a new robotic imaging device, and reorganizing... View Details
Keywords: Surgery; Robotics; Health Care; Private Healthcare; Pricing; Technology Platform; Acquisition; Business Growth and Maturation; Growth and Development Strategy; Business Strategy; Corporate Strategy; Corporate Entrepreneurship; Health Care and Treatment; Health; Innovation and Invention; Innovation and Management; Innovation Strategy; Technological Innovation; Applications and Software; Information Infrastructure; Information Technology; Digital Platforms; Health Industry; Europe; Germany; Munich
Citation
Educators
Purchase
Related
Herzlinger, Regina E., Gregory P. Licholai, and Federica Gabrieli. "Brainlab: Imaging a MedTech Future." Harvard Business School Case 321-087, February 2021. (Revised June 2021.)
  • February 2009 (Revised December 2009)
  • Case

Merck: Global Health and Access to Medicines

By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social... View Details
Keywords: Globalized Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Poverty; Business Strategy; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Rangan, V. Kasturi, and Katharine Lee. "Merck: Global Health and Access to Medicines." Harvard Business School Case 509-048, February 2009. (Revised December 2009.)
  • January 2019
  • Teaching Note

Pricing PatientPing

By: Frank V. Cespedes
Teaching Note for HBS No. 818-017. PatientPing sells a software platform that allows health care providers to receive real-time notifications (“pings”) when one of their patients is admitted to or discharged from a health-care facility. The platform facilitates... View Details
Keywords: Pricing; Health Tech; Health Technology; Sales Process; Sales Strategy; Price; Sales; Marketing Strategy; Health Care and Treatment; Health Industry; Health Industry; United States; Massachusetts
Citation
Purchase
Related
Cespedes, Frank V. "Pricing PatientPing." Harvard Business School Teaching Note 819-098, January 2019.
  • 2004
  • Book

Consumer-Driven Health Care: Implications for Providers, Payers, and Policymakers

By: Regina E. Herzlinger
Keywords: Customers; Health Care and Treatment; Health Industry
Citation
Find at Harvard
Related
Herzlinger, Regina E. Consumer-Driven Health Care: Implications for Providers, Payers, and Policymakers. San Francisco: Jossey-Bass, 2004.
  • 09 Nov 2023
  • HBS Case

What Will It Take to Confront the Invisible Mental Health Crisis in Business?

As a finance specialist, Harvard Business School Professor Lauren Cohen works to understand the dynamics that make businesses thrive. In his recent research on family companies, he has found one common thread among successful firms: They... View Details
Keywords: by Kara Baskin; Health
  • January 2017 (Revised March 2021)
  • Case

Fitbit

By: Regina E. Herzlinger, Christine Snively and Sarah Mehta
In 2019, Fitbit lost its leadership in the wearable sensor market to Apple and to cheaper alternatives.
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details
Keywords: Wearable Sensors; Smart Watches In Health Care; Google Acquisition; Health Care and Treatment; Information Technology; Acquisition
Citation
Educators
Purchase
Related
Herzlinger, Regina E., Christine Snively, and Sarah Mehta. "Fitbit." Harvard Business School Case 317-007, January 2017. (Revised March 2021.)
  • ←
  • 69
  • 70
  • …
  • 275
  • 276
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.